Global Sources Ltd. (GSOL) Jumps 11.8% on December 31

Equities Staff  |

Global Sources Ltd. (GSOL) was among the biggest gainers on the Russell 2000 for Thursday December 31 as the stock popped 11.8% to $7.58, representing a gain of $0.8 per share. Some 30,162 shares traded hands on 211 trades, compared with an average daily volume of 22,519 shares out of a total float of 23.6 million. The stock opened at $6.73 and traded with an intraday range of $7.63 to $6.73.

After today's gains, Global Sources Ltd. reached a market cap of $178.87 million. Global Sources Ltd. has had a trading range between $9.75 and $5.07 over the last year, and it had a 50-day SMA of $8.67 and a 200-day SMA of $7.36.

The stock has a P/E Ratio of 12.1.

Global Sources Ltd is a business-to-business media company that provides information and integrated marketing services with online, trade publications, trade shows, advertising and creative well as sourcing reports.

Global Sources Ltd. is based out of Hamilton, and has some 505 employees. Its CEO is Spenser Au.

For a complete fundamental analysis analysis of Global Sources Ltd., check out’s Stock Valuation Analysis report for GSOL. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

Global Cannabis

Global Cannabis Applications Corp is engaged in the design, acquire data and develop applications for smartphones and tablets. The company offer Citizen Green platform, an end to end infrastructure to…